Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sophora japonica granules are a Traditional Chinese Medicine (TCM) preparation derived from the dried flowers or buds of *Styphnolobium japonicum* (formerly *Sophora japonica*). These granules are produced as concentrated extracts, often referred to as formula granules, which are standardized to contain high levels of flavonoids, most notably rutin (quercetin-3-rutinoside) and quercetin. The drug is primarily indicated for its hemostatic properties, used to treat conditions such as hemorrhoids, hematochezia (bloody stools), epistaxis, and functional uterine bleeding. Mechanistically, the active flavonoids stabilize capillary walls, reduce vascular permeability, and exert anti-inflammatory effects by inhibiting enzymes such as hyaluronidase and cyclooxygenase-2 (COX-2). In clinical practice, they are valued for their ability to "cool the blood" and stop bleeding according to TCM principles.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on sophora japonica granules.